Telix Pharmaceuticals | TLX - Trade Debtors


Telix Pharmaceuticals reported AUD170.39M in Trade Debtors for its fiscal semester ending in June of 2026.





Trade Debtors Change Date
Cochlear AUD 568.4M 17.5M Dec/2025
CSL USD 4.32B 1.35B Dec/2025
Integral Diagnostics AUD 24.82M 10.78M Jun/2024
Mayne Pharma AUD 193.22M 5.64M Jun/2024
Medical Developments International AUD 7.48M 174K Dec/2025
Mesoblast USD 57.66M 14.36M Jun/2026
Neuren Pharmaceuticals AUD 26.54M 5.83M Dec/2025
Pacific Edge NZD 2.46M 1.29M Jun/2026
Paradigm Biopharmaceuticals AUD 6.31M 58.85K Dec/2025
Polynovo AUD 24.21M 945K Dec/2025
PYC Therapeutics AUD 32.59M 8.52M Dec/2025
Ramsay Health Care AUD 2.48B 22.3M Dec/2025
ResMed USD 1.05B 1.1M Mar/2026
Sonic Healthcare AUD 1.39B 23.76M Dec/2024